GlassScriptPhysician profile
Christopher Ryan Urban
NPI 1508183286
$1,701.07
in general payments reported to CMS, 2019-2025
21 companies · $596 in 2025
The $596 reported for 2025 was less than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $236 · 2021: $167 · 2022: $32.71 · 2023: $95.92 · 2024: $98.02 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $790.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $414.91 | 2019-2025 | |
| Galderma Laboratories, L.P. | $237.72 | 2019-2025 | Nemluvio, Dysport |
| Janssen Biotech, INC. | $209.90 | 2019-2025 | Tremfya |
| Genzyme Corporation | $195.89 | 2019-2023 | |
| Genentech USA, INC. | $131.35 | 2019-2021 | |
| Pfizer INC. | $86.62 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $62.77 | 2023-2025 | Blu-U, Odomzo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $56.49 | 2019-2020 | |
| Merz North America, INC. | $49.23 | 2019 | |
| Ucb, INC. | $43.83 | 2024-2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $32.42 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $28.62 | 2019-2024 | |
| Incyte Corporation | $23.80 | 2025 | Opzelura |
| Dermavant Sciences, INC. | $20.43 | 2023 | Vtama |
| Almirall LLC | $17.91 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $17.22 | 2021 | |
| Amgen INC. | $16.31 | 2020 | |
| Paratek Pharmaceuticals, INC. | $15.51 | 2025 | Nuzyra |
| Dusa Pharmaceuticals, INC. | $14.24 | 2019 | |
| Integra Lifesciences Corporation | $13.18 | 2020 | |
| Leo Pharma INC. | $12.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Urban listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.